vs
ARBOR REALTY TRUST INC（ABR）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
ARBOR REALTY TRUST INC的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.8倍（$133.4M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -12.1%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -8.9%）
Arbor Realty Trust Inc.是总部位于美国的专业房地产投资信托（REIT）企业，主要为多户住宅及商业地产项目提供结构性融资服务，涵盖过渡贷款、机构贷款、夹层融资等品类，服务覆盖美国各地的地产持有者、开发商及房产投资群体。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
ABR vs PBYI — 直观对比
营收规模更大
ABR
是对方的1.8倍
$75.5M
营收增速更快
PBYI
高出39.8%
-12.1%
两年增速更快
PBYI
近两年复合增速
-8.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $133.4M | $75.5M |
| 净利润 | — | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | — | — |
| 营收同比 | -12.1% | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.08 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABRPBYI
| Q4 25 | $133.4M | $75.5M | ||
| Q3 25 | $112.4M | $54.5M | ||
| Q2 25 | $130.4M | $52.4M | ||
| Q1 25 | $134.2M | $46.0M | ||
| Q4 24 | $151.7M | $59.1M | ||
| Q3 24 | $156.7M | $80.5M | ||
| Q2 24 | $153.1M | $47.1M | ||
| Q1 24 | $160.7M | $43.8M |
净利润ABRPBYI
| Q4 25 | — | — | ||
| Q3 25 | $52.0M | $8.8M | ||
| Q2 25 | $36.3M | $5.9M | ||
| Q1 25 | $43.4M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $73.5M | $20.3M | ||
| Q2 24 | $61.8M | $-4.5M | ||
| Q1 24 | $73.2M | $-4.8M |
毛利率ABRPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率ABRPBYI
| Q4 25 | — | 22.7% | ||
| Q3 25 | — | 17.6% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | — | 27.4% | ||
| Q2 24 | — | -4.6% | ||
| Q1 24 | 46.9% | -5.3% |
净利率ABRPBYI
| Q4 25 | — | — | ||
| Q3 25 | 46.3% | 16.2% | ||
| Q2 25 | 27.8% | 11.2% | ||
| Q1 25 | 32.3% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 46.9% | 25.2% | ||
| Q2 24 | 40.4% | -9.6% | ||
| Q1 24 | 45.6% | -11.0% |
每股收益（稀释后）ABRPBYI
| Q4 25 | $0.08 | $0.26 | ||
| Q3 25 | $0.20 | $0.17 | ||
| Q2 25 | $0.12 | $0.12 | ||
| Q1 25 | $0.16 | $0.06 | ||
| Q4 24 | $0.31 | $0.40 | ||
| Q3 24 | $0.31 | $0.41 | ||
| Q2 24 | $0.25 | $-0.09 | ||
| Q1 24 | $0.31 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $482.9M | $97.5M |
| 总债务越低越好 | $11.1B | $22.7M |
| 股东权益账面价值 | $3.0B | $130.3M |
| 总资产 | $14.5B | $216.3M |
| 负债/权益比越低杠杆越低 | 3.75× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资ABRPBYI
| Q4 25 | $482.9M | $97.5M | ||
| Q3 25 | $423.4M | $94.4M | ||
| Q2 25 | $255.7M | $96.0M | ||
| Q1 25 | $308.8M | $93.2M | ||
| Q4 24 | $503.8M | $101.0M | ||
| Q3 24 | $687.5M | $96.7M | ||
| Q2 24 | $737.5M | $96.8M | ||
| Q1 24 | $908.0M | $107.2M |
总债务ABRPBYI
| Q4 25 | $11.1B | $22.7M | ||
| Q3 25 | $10.4B | $34.0M | ||
| Q2 25 | $10.1B | $45.3M | ||
| Q1 25 | $9.9B | $56.7M | ||
| Q4 24 | $10.0B | $68.0M | ||
| Q3 24 | $10.3B | $79.3M | ||
| Q2 24 | $10.6B | $90.7M | ||
| Q1 24 | $11.4B | $102.0M |
股东权益ABRPBYI
| Q4 25 | $3.0B | $130.3M | ||
| Q3 25 | $3.0B | $115.3M | ||
| Q2 25 | $3.0B | $104.7M | ||
| Q1 25 | $3.0B | $97.1M | ||
| Q4 24 | $3.0B | $92.1M | ||
| Q3 24 | $3.0B | $71.1M | ||
| Q2 24 | $3.1B | $48.5M | ||
| Q1 24 | $3.1B | $51.0M |
总资产ABRPBYI
| Q4 25 | $14.5B | $216.3M | ||
| Q3 25 | $13.9B | $202.9M | ||
| Q2 25 | $13.6B | $194.9M | ||
| Q1 25 | $13.4B | $196.2M | ||
| Q4 24 | $13.5B | $213.3M | ||
| Q3 24 | $13.9B | $220.7M | ||
| Q2 24 | $14.2B | $205.0M | ||
| Q1 24 | $15.1B | $214.1M |
负债/权益比ABRPBYI
| Q4 25 | 3.75× | 0.17× | ||
| Q3 25 | 3.47× | 0.30× | ||
| Q2 25 | 3.40× | 0.43× | ||
| Q1 25 | 3.29× | 0.58× | ||
| Q4 24 | 3.29× | 0.74× | ||
| Q3 24 | 3.40× | 1.12× | ||
| Q2 24 | 3.47× | 1.87× | ||
| Q1 24 | 3.68× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $372.4M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流ABRPBYI
| Q4 25 | $372.4M | $14.4M | ||
| Q3 25 | $178.7M | $9.7M | ||
| Q2 25 | $60.0M | $14.1M | ||
| Q1 25 | $150.5M | $3.6M | ||
| Q4 24 | $461.5M | $15.6M | ||
| Q3 24 | $85.0M | $11.0M | ||
| Q2 24 | $69.9M | $1.0M | ||
| Q1 24 | $260.0M | $11.2M |
自由现金流ABRPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率ABRPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度ABRPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率ABRPBYI
| Q4 25 | — | — | ||
| Q3 25 | 3.44× | 1.10× | ||
| Q2 25 | 1.65× | 2.41× | ||
| Q1 25 | 3.47× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.16× | 0.54× | ||
| Q2 24 | 1.13× | — | ||
| Q1 24 | 3.55× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
